Three firms completed initial public offerings (IPOs) last week. One was an uplisted offering from Kura Oncology Inc. (NASDAQ: KURA) from the OTCQB venture marketplace. Another was First Guaranty Bancshares Inc. (NASDAQ: FGBI), which both downsized the number of shares to be sold and lowered the IPO price. And Fuling Global Inc. (NASDAQ: FORK), a China-based maker of plastic cutlery, had to settle for a “best-efforts” IPO. Paris-based GenSight Biologics postponed its IPO.

Through the week ending November 6, IPO ETF manager Renaissance Capital reported that 156 IPOs have priced in the United States so far this year, down nearly 36% from a year ago. Total proceeds raised through last week equaled $28.2 billion, down about 63% compared with the same period in 2014. Of the 156 IPOs that have gone off this year, 73 have come from the health care sector. Last year’s IPO total came in at $85.2 billion, the highest total in the past 10 years. Renaissance Capital does not include best efforts or blank-check companies in its totals.

Two holdovers and seven new entries are on the coming week’s calendar, including four biotechs and two financial companies.

One firm returning for another try next week is Xtera Communications, a developer of high-capacity optical transport products. The company plans to offer 5.5 million shares in an IPO price range of $9 to $11 to raise $55 million at an implied market cap of $176 million. Joint bookrunners for the offering are Needham, Cowen and BMO Capital Markets. Shares are expected to price and begin trading next week on the Nasdaq under the ticker symbol XCOM.

ALSO READ: 10 Brands That Will Disappear in 2016

The other holdover is Sole Elite Group, a China-based maker of shoe soles used in the manufacture of sports shoes. The company has slashed the number of shares it plans to offer and added a warrant to each share that is exercisable at 120% of the IPO price. The firm also lowered its expected price range to $5.50 to $7.00. Joint bookrunners for the offering are Dawson James and ViewTrade. The shares are shown as day-to-day and will trade on the Nasdaq under the ticker symbol SOLE.
Advanced Accelerator Applications is a France-based radiopharmaceutical company that develops, produces and commercializes molecular nuclear medicine products. The company plans to offer 4.7 million American depositary shares (ADS) in an expected price range of $15 to $17. Each ADS represents to two ordinary shares. Joint bookrunners for the offering are Citi and Jefferies. Co-managers are Canaccord Genuity and JMP Securities. The ADSs are scheduled to price on Tuesday and begin trading Wednesday on the Nasdaq under the ticker symbol AAAP.

Equity Bancshares is a bank holding company headquartered in Wichita, Kan. The commercial bank plans to offer 1.8 million shares in an expected price range of $22 to $24 to raise $41.2 million at an implied market cap of $154.3 million. Joint bookrunners for the offering are Keefe Bruyette Woods and Stephens. Co-manager is Sandler O’Neill. Shares are scheduled to price on Tuesday and begin trading Wednesday on the Nasdaq under the ticker symbol EQBK.

Mesoblast is an Australia-based regenerative medicine firm. The offering is a transplant the Australian Securities Exchange and includes 5.7 million ADSs at an expected price of $12.10. Each ADS represents to five ordinary shares. The company expects to raise $69.5 million at a market cap of $885 million. Joint bookrunners for the offering are JPMorgan and Credit Suisse. Co-managers are Maxim Group and Ladenburg Thalmann. The ADSs are scheduled to price on Tuesday and begin trading Wednesday on the Nasdaq under the ticker symbol MESO.

Voyager Therapeutics is a clinical-stage gene therapy company that is developing treatments for patients suffering from severe diseases of the central nervous system. The company is offering 4.7 million shares in an expected price range of $15 to $17 to raise $75 million at an implied market cap of $411.5 million. Joint bookrunners for the offering are Cowen and Piper Jaffray. Co-managers are Wedbush PacGrow and Nomura Securities. Shares are scheduled to price on Tuesday and begin trading Wednesday on the Nasdaq under the ticker symbol VYGR.

ALSO READ: America’s 50 Best Cities to Live In

Wave Life Sciences is a Singapore-based preclinical biopharmaceutical company with a proprietary synthetic chemistry drug development platform that it uses to design, develop and commercialize a broad pipeline of nucleic acid therapeutic candidates. The company plans to offer 5 million shares in an expected price range of $15 to $17, raising $80 million at an implied market cap of $312.9 million. Joint bookrunners for the offering are Jefferies and Leerink Partners. Co-managers are JMP Securities and SunTrust Robinson Humphrey. Shares are scheduled to price on Tuesday and begin trading Wednesday on the Nasdaq under the ticker symbol WVE.

Instructure is a cloud-based learning management platform for academic institutions and companies worldwide. The company plans to offer 4.4 million shares in an expected price range of $16 to $18 to raise $74.8 million at an implied market cap of $448.6 million. Joint bookrunners for the offering are Morgan Stanley, Goldman Sachs and Jefferies. Co-managers are Needham, Oppenheimer and Raymond James. Shares are scheduled to price on Thursday and begin trading Friday on the New York Stock Exchange under the ticker symbol INST.

loanDepot is a technology-enabled U.S. consumer lending platform. The company plans to offer 30 million shares in an expected price range of $16 to $18. Joint bookrunners for the offering are Morgan Stanley, Goldman Sachs, Wells Fargo Securities, Barclays, UBS Investment Bank and Citi. Co-managers include BMO Capital Markets, JMP Securities, Raymond James and William Blair. Shares are scheduled to price on Thursday and begin trading Friday on the New York Stock Exchange under the ticker symbol LDI.

ALSO READ: Best (and Worst) Countries for Business

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.